The monoclonal antibody idarucizumab is able to counteract the effect of the non-vitamin K antagonist oral anticoagulant dabigatran in the majority of patients. That is the conclusion of a recent publication in The New England Journal of Medicine. These results imply that the irreversibility of effect of dabigatran is now no longer an issue. Continue reading
Showing articles tagged with 'Umcg'
In children, CT scans have more downsides than benefits. Often, no extra information is obtained and non-radiation alternatives are equally suitable. This conclusion was presented by surgeon David Nellensteijn, who defended his thesis ‘Paediatric abdominal injury: Initial treatment and diagnostics’ on April 1st, 2015, at the university of Groningen. Continue reading